Function and clinical significance of N6-methyladenosine in digestive system tumours
Abstract RNA modification, like DNA methylation, histone modification, non-coding RNA modification and chromatin rearrangement, plays an important role in tumours. N6-methyladenosine (m6A) is the most abundant RNA modification in cells, and it regulates RNA transcription, processing, splicing, degra...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | Experimental Hematology & Oncology |
Online Access: | https://doi.org/10.1186/s40164-021-00234-1 |
id |
doaj-c33530d67350480196c895b1659c905c |
---|---|
record_format |
Article |
spelling |
doaj-c33530d67350480196c895b1659c905c2021-07-11T11:12:51ZengBMCExperimental Hematology & Oncology2162-36192021-07-0110111510.1186/s40164-021-00234-1Function and clinical significance of N6-methyladenosine in digestive system tumoursJunchao Huang0Yingjie Shao1Wendong Gu2Department of Radiation Oncology, The Third Affiliated Hospital of Soochow UniversityDepartment of Radiation Oncology, The Third Affiliated Hospital of Soochow UniversityDepartment of Radiation Oncology, The Third Affiliated Hospital of Soochow UniversityAbstract RNA modification, like DNA methylation, histone modification, non-coding RNA modification and chromatin rearrangement, plays an important role in tumours. N6-methyladenosine (m6A) is the most abundant RNA modification in cells, and it regulates RNA transcription, processing, splicing, degradation, and translation. m6A-associated proteins have been used as new biomarkers and therapeutic targets for tumour prediction and monitoring. There are three main types of proteins involved in m6A methylation: methyltransferases (METTL3, METTL14, WTAP, RBM15, ZC3H13 and KIAA1429), demethylases (FTO, ALKBH5 and ALKBH3) and RNA-binding proteins (YTHDF1-3, YTHDC1-2, IGF2BPs and HNRNPs). This article reviews the origins, characteristics and functions of m6A and its relationship with digestive system tumours based on recent research. The expression of m6A regulators can be used as an evaluation indicator of tumour growth and progression and as a prognostic indicator. In-depth research on m6A methylation in digestive system tumours may provide new directions for clinical prediction and further treatment.https://doi.org/10.1186/s40164-021-00234-1 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Junchao Huang Yingjie Shao Wendong Gu |
spellingShingle |
Junchao Huang Yingjie Shao Wendong Gu Function and clinical significance of N6-methyladenosine in digestive system tumours Experimental Hematology & Oncology |
author_facet |
Junchao Huang Yingjie Shao Wendong Gu |
author_sort |
Junchao Huang |
title |
Function and clinical significance of N6-methyladenosine in digestive system tumours |
title_short |
Function and clinical significance of N6-methyladenosine in digestive system tumours |
title_full |
Function and clinical significance of N6-methyladenosine in digestive system tumours |
title_fullStr |
Function and clinical significance of N6-methyladenosine in digestive system tumours |
title_full_unstemmed |
Function and clinical significance of N6-methyladenosine in digestive system tumours |
title_sort |
function and clinical significance of n6-methyladenosine in digestive system tumours |
publisher |
BMC |
series |
Experimental Hematology & Oncology |
issn |
2162-3619 |
publishDate |
2021-07-01 |
description |
Abstract RNA modification, like DNA methylation, histone modification, non-coding RNA modification and chromatin rearrangement, plays an important role in tumours. N6-methyladenosine (m6A) is the most abundant RNA modification in cells, and it regulates RNA transcription, processing, splicing, degradation, and translation. m6A-associated proteins have been used as new biomarkers and therapeutic targets for tumour prediction and monitoring. There are three main types of proteins involved in m6A methylation: methyltransferases (METTL3, METTL14, WTAP, RBM15, ZC3H13 and KIAA1429), demethylases (FTO, ALKBH5 and ALKBH3) and RNA-binding proteins (YTHDF1-3, YTHDC1-2, IGF2BPs and HNRNPs). This article reviews the origins, characteristics and functions of m6A and its relationship with digestive system tumours based on recent research. The expression of m6A regulators can be used as an evaluation indicator of tumour growth and progression and as a prognostic indicator. In-depth research on m6A methylation in digestive system tumours may provide new directions for clinical prediction and further treatment. |
url |
https://doi.org/10.1186/s40164-021-00234-1 |
work_keys_str_mv |
AT junchaohuang functionandclinicalsignificanceofn6methyladenosineindigestivesystemtumours AT yingjieshao functionandclinicalsignificanceofn6methyladenosineindigestivesystemtumours AT wendonggu functionandclinicalsignificanceofn6methyladenosineindigestivesystemtumours |
_version_ |
1721309271284514816 |